Researchers have analysed the therapeutic benefits of an antiviral drug, nirmatrelvir, and a class of drugs typically used for bone disorders, bisphosphonates, on the coronavirus. Nirmatrelvir treatment proved effective in preventing severe disease but might impact the host immune system’s ability to combat the virus in future. Meanwhile, bisphosphonates were found to enhance antibody responses to viral antigens, reducing COVID-19 risk and hospitalisation rates.
Researchers discover first UEFI bootkit malware for Linux
Named “Bootkitty”, the first UEFI bootkit targeting Linux systems has been detected by ESET researchers. Operating before the system’s boot process begins enables Bootkitty to
